DK1027063T3 - Mannosereceptorbærende cellelinje og antigensammensætning - Google Patents

Mannosereceptorbærende cellelinje og antigensammensætning

Info

Publication number: DK1027063T3
Authority: DK; Denmark
Prior art keywords: cell line; mannose receptor; antigen composition; antigen; carrying cell
Prior art date: 1997-09-29

Application number

DK98947738T

Other languages

Danish (da)

English (en)

Inventor

Vasso Apostolopoulos

Ian F C Mckenzie

Geoffrey A Pietersz

Original Assignee

Macfarlane Burnet Inst For Med

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-09-29

Filing date

1998-09-29

Publication date

2009-06-02

1998-09-29 Application filed by Macfarlane Burnet Inst For Med filed Critical Macfarlane Burnet Inst For Med

2009-06-02 Application granted granted Critical

2009-06-02 Publication of DK1027063T3 publication Critical patent/DK1027063T3/da

Links

239000000427 antigen Substances 0.000 title abstract 3
108091007433 antigens Proteins 0.000 title abstract 3
102000036639 antigens Human genes 0.000 title abstract 3
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 title abstract 2
229920001282 polysaccharide Polymers 0.000 abstract 3
210000000612 antigen-presenting cell Anatomy 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
108010031099 Mannose Receptor Proteins 0.000 abstract 1
150000001299 aldehydes Chemical class 0.000 abstract 1
210000001151 cytotoxic T lymphocyte Anatomy 0.000 abstract 1
238000000338 in vitro Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/17—Monocytes; Macrophages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/19—Dendritic cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/24—Antigen-presenting cells [APC]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A61K40/4256—Tumor associated carbohydrates
- A61K40/4257—Mucins, e.g. MUC-1
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0645—Macrophages, e.g. Kuepfer cells in the liver; Monocytes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/25—Tumour necrosing factors [TNF]
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Virology (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Microbiology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Gastroenterology & Hepatology (AREA)
Pulmonology (AREA)
Tropical Medicine & Parasitology (AREA)
Mycology (AREA)
Biochemistry (AREA)
Hematology (AREA)
General Engineering & Computer Science (AREA)
Cell Biology (AREA)
Neurology (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Ophthalmology & Optometry (AREA)
Neurosurgery (AREA)

DK98947738T 1997-09-29 1998-09-29 Mannosereceptorbærende cellelinje og antigensammensætning DK1027063T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US6059497P	1997-09-29	1997-09-29
PCT/IB1998/001718 WO1999016455A1 (en)	1997-09-29	1998-09-29	Mannose receptor bearing cell line and antigen composition

Publications (1)

Publication Number	Publication Date
DK1027063T3 true DK1027063T3 (da)	2009-06-02

Family

ID=22030506

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK98947738T DK1027063T3 (da)	1997-09-29	1998-09-29	Mannosereceptorbærende cellelinje og antigensammensætning

Country Status (10)

Country	Link
US (1)	US8771701B2 (de)
EP (1)	EP1027063B1 (de)
JP (2)	JP4669930B2 (de)
AT (1)	ATE422893T1 (de)
AU (1)	AU754065B2 (de)
CA (1)	CA2304952C (de)
DE (1)	DE69840578D1 (de)
DK (1)	DK1027063T3 (de)
ES (1)	ES2322212T3 (de)
WO (1)	WO1999016455A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8021667B2 (en) *	1994-11-16	2011-09-20	Macfarlane Burnet Institute For Medical Research And Public Health Ltd	Compositions for immunotherapy and uses thereof
US7560534B2 (en)	2000-05-08	2009-07-14	Celldex Research Corporation	Molecular conjugates comprising human monoclonal antibodies to dendritic cells
KR100643818B1 (ko)	2000-05-08	2006-11-10	셀덱스 쎄라퓨틱스, 인크.	수상세포에 대한 인간 모노클로날 항체
AU2001263653B2 (en) *	2000-06-06	2006-06-29	Igavax Pty Ltd	Vaccine
AUPQ797700A0 (en)	2000-06-06	2000-06-29	Austin Research Institute, The	Vaccine
US9243064B2 (en)	2003-01-31	2016-01-26	Celldex Therapeutics Inc.	Antibody vaccine conjugates and uses therefor
US9259459B2 (en)	2003-01-31	2016-02-16	Celldex Therapeutics Inc.	Antibody vaccine conjugates and uses therefor
KR101811965B1 (ko)	2007-11-07	2017-12-22	셀덱스 쎄라퓨틱스, 인크.	인간 수지상 및 상피 세포 205(ｄｅｃ-205)에 결합하는 항체
AU2009236585B2 (en)	2008-04-18	2013-03-07	Vaxinnate Corporation	Deletion mutants of flagellin and methods of use
AU2012334825B2 (en) *	2011-11-09	2017-08-24	Ascend Biopharmaceuticals Ltd	Immunomodulatory conjugates
EP2872621B1 (de) *	2012-07-16	2018-10-31	Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.	Verfahren zur erzeugung nicht transformierter makrophagenzelllinien
WO2015119180A1 (ja) *	2014-02-06	2015-08-13	医化学創薬株式会社	ムチン４（ｍｕｃ４）糖ペプチドに対する抗体及びその用途
CN104721795A (zh) *	2015-04-05	2015-06-24	四川双鑫生物科技有限公司	一种治疗百日咳的内服药物及其制备方法
CN115666619A (zh) *	2020-04-13	2023-01-31	埃索普罗瑟医疗有限公司	用于抗病毒治疗的包含野生型p53蛋白的细胞衍生囊泡

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2279422A2 (fr)	1974-07-22	1976-02-20	Inst Nat Sante Rech Med	Forme pharmaceutique a base d'interferon
US4720386A (en)	1976-11-24	1988-01-19	Mccollester Duncan L	Vaccine and method for immunotherapy of neoplastic disease
JPS61112023A (ja)	1984-11-05	1986-05-30	Tanabe Seiyaku Co Ltd	がん細胞傷害活性物質の新規製法
JP2594123B2 (ja)	1987-09-12	1997-03-26	株式会社林原生物化学研究所	減感作剤
EP0326111A3 (de)	1988-01-29	1989-12-27	New York Blood Center, Inc.	Peptid-Derivate, immunogenisch gemacht bei Verabreichung zusammen mit Alaun als Zusatzmittel
US5047227A (en)	1988-02-08	1991-09-10	Cytogen Corporation	Novel and improved antibodies for site specific attachment of compounds
EP0357767B1 (de)	1988-03-11	1995-05-24	The Biomembrane Institute	Monoklonale antikörper und herstellung eines impfstoffes gegen menschliche krebsantigene durch immunisierung mit menschlichem und tierischem mucin und mit synthetischen gluciden-trägerkonjugaten
US5229289A (en)	1988-03-11	1993-07-20	The Biomembrane Institute	Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human and with synthetic carbohydrate-carrier conjugates
JPH01233219A (ja)	1988-03-12	1989-09-19	Nippon Oil & Fats Co Ltd	制癌剤組成物
AU620149B2 (en)	1988-08-18	1992-02-13	Vaxine Pty Ltd	Gamma inulin compositions
EP0442926A1 (de)	1988-11-10	1991-08-28	Imperial Cancer Research Technology Limited	Polypeptide
US6605712B1 (en)	1990-12-20	2003-08-12	Arch Development Corporation	Gene transcription and ionizing radiation: methods and compositions
DK0563278T3 (da)	1990-12-20	2000-08-21	Dana Farber Cancer Inst Inc	Regulering af geneekspression med ioniserende stråling
US5432260A (en) *	1991-05-03	1995-07-11	Washington University	High affinity mannose receptor ligands
WO1993006858A1 (en)	1991-10-09	1993-04-15	Dana Farber Cancer Institute, Inc.	Lung cancer-associated protein
IL104382A0 (en)	1992-01-17	1993-05-13	Solvay Animal Health Inc	Vaccine containing acemannan as an adjuvant
JP3043888B2 (ja)	1992-02-20	2000-05-22	森永乳業株式会社	グルコマンナン部分加水分解物を有効成分とする大腸ガン予防剤
IT1262896B (it)	1992-03-06	1996-07-22		Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
US5820872A (en)	1992-11-18	1998-10-13	Yale University	Methods and compositions for improving the effectiveness of X-irradiation therapy for the treatment of an internal solid tumor
AU5675794A (en)	1992-12-15	1994-07-04	Board Of Trustees Of The Leland Stanford Junior University	Mucosal vascular addressin, dna and expression
AUPM322393A0 (en)	1993-12-24	1994-01-27	Austin Research Institute, The	Mucin carbohydrate compounds and their use in immunotherapy
US8021667B2 (en)	1994-11-16	2011-09-20	Macfarlane Burnet Institute For Medical Research And Public Health Ltd	Compositions for immunotherapy and uses thereof
US6017527A (en)	1996-07-10	2000-01-25	Immunex Corporation	Activated dendritic cells and methods for their activation
EP0849275A1 (de)	1996-09-26	1998-06-24	Rijksuniversiteit te Leiden	Mannosylierte Peptide
JP5246860B2 (ja)	2008-09-29	2013-07-24	株式会社前川製作所	急速熱処理装置及び急速熱処理装置用ノズル

1998
- 1998-09-29 DK DK98947738T patent/DK1027063T3/da active
- 1998-09-29 JP JP2000513589A patent/JP4669930B2/ja not_active Expired - Fee Related
- 1998-09-29 ES ES98947738T patent/ES2322212T3/es not_active Expired - Lifetime
- 1998-09-29 WO PCT/IB1998/001718 patent/WO1999016455A1/en not_active Ceased
- 1998-09-29 DE DE69840578T patent/DE69840578D1/de not_active Expired - Lifetime
- 1998-09-29 EP EP98947738A patent/EP1027063B1/de not_active Expired - Lifetime
- 1998-09-29 CA CA2304952A patent/CA2304952C/en not_active Expired - Fee Related
- 1998-09-29 AU AU94555/98A patent/AU754065B2/en not_active Ceased
- 1998-09-29 AT AT98947738T patent/ATE422893T1/de active
2006
- 2006-11-17 US US11/561,204 patent/US8771701B2/en not_active Expired - Fee Related
2010
- 2010-10-06 JP JP2010226648A patent/JP5192020B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1027063A4 (de)	2004-12-08
DE69840578D1 (de)	2009-04-02
US20070071765A1 (en)	2007-03-29
CA2304952A1 (en)	1999-04-08
JP5192020B2 (ja)	2013-05-08
CA2304952C (en)	2012-01-03
ES2322212T3 (es)	2009-06-17
JP2001517709A (ja)	2001-10-09
JP2011046723A (ja)	2011-03-10
EP1027063B1 (de)	2009-02-18
JP4669930B2 (ja)	2011-04-13
US8771701B2 (en)	2014-07-08
ATE422893T1 (de)	2009-03-15
WO1999016455A1 (en)	1999-04-08
AU754065B2 (en)	2002-11-07
EP1027063A1 (de)	2000-08-16
AU9455598A (en)	1999-04-23

Publication	Publication Date	Title
ATE422893T1 (de)	2009-03-15	Mannose-rezeptor tragende zellinie und antigen zusammensetzung
AU560045B2 (en)	1987-03-26	Latex graft copolymer containing aldehyde realtive with biological agents
DK0870022T3 (da)	2007-05-21	Immunstimulerende sammensætning og fremgangsmåde
MY101593A (en)	1991-12-17	Sustained release preparation.
ATE186632T1 (de)	1999-12-15	Verabreichung einer substanz in den mund
ATE255382T1 (de)	2003-12-15	Stent aus einer formgedächnislegierung
ATE199096T1 (de)	2001-02-15	Il-11 aus säugetier
WO1995034320A3 (en)	1996-01-18	Methods for inhibiting antigen specific t cell responses
DK0771216T3 (da)	2001-02-05	Fremgangsmåder og præparater til specifik koagulering af tumorvaskulatur
ES2073394T3 (es)	1995-08-16	Constructos de anticuerpos bifuncionales y su utilizacion para destruir selectivamente las poblaciones celulares.
ES2124668B1 (es)	1999-08-16	"nuevosl-arilpirazoles con propiedades plaguicidas.
TR199701547T1 (xx)	1998-03-21	Polisakarit antijen protein e�leni�i i�eren a��.
CO4810339A1 (es)	1999-06-30	Nuevas estructuras artificiales de proteinas de fusion y metodo de preparacion
BR9910251A (pt)	2001-01-02	Estimulação hematopoiética
TR200001021T2 (tr)	2000-09-21	Aktif maddelerin kontrollü salınması için biyo aşındırılabilir makromerler.
TR199801179T2 (xx)	1998-10-21	Yeni taksoitler, bunlar�n haz�rlanmalar� ve ila� bile�imleri.
TR199800607T1 (xx)	1998-06-22	Dendritik h�cre uyar�c� fakt�r�.
EE03955B1 (et)	2003-02-17	Nukleiinhappe kasutamine ravimi valmistamiseks imetaja reproduktiivtrakti vähemalt mõne raku transfekteerimiseks
YU49314B (sh)	2005-06-10	Postupak za pripremanje 1-(2'-deoksi-2',2'-difluoro-d-ribofuranosil)-4-aminopirimidin-2-on)hidrohlorida
ES2053815T3 (es)	1994-08-01	Preparacion farmaceutica con liberacion prolongada de una dihidropiridina y un antagonista de un beta-adrenorreceptor y un procedimiento para su preparacion.
NO971341L (no)	1997-05-14	Promoter for reseptor tyrosinkinase TIE
ES2095154T3 (es)	1997-02-01	Alquilglicosidos en tintes.
ES2150950T3 (es)	2000-12-16	Marcado de moleculas utilizando derivados de 2-hidrazinopiridina.
EP1211311A3 (de)	2003-11-05	Aktivierte Lymphocyten aus Nabelstrangblut und Zusammensetzungen davon
DK0752102T3 (da)	2001-01-08	Immunoenzymatisk konjugat, fremgangsmåde til fremstilling af konjugatet og anvendelse af dette.